Lynch syndrome is characterized by inactivating germline mutations to MSH2, MSH6, PMS2, or MLH1, whereas MLH1 expression is silenced due to biallelic hypermethylation in sporadic CRC [228], [229], [230], [231], [232]. The gene discussed is MLH1; the disease is colorectal carcinoma.